NCT00743314View on ClinicalTrials.gov

Single-Photon Emission Computed Tomography, Computed Tomography Lymphoscintigraphy, and Intensity-Modulated Radiation Therapy in Treating Patients Who Have Undergone Surgery for Stage I or Stage II Breast Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Breast CancerLymphedema
Interventions
OTHER

screening questionnaire administration

PROCEDURE

computed tomography

PROCEDURE

lymphoscintigraphy

PROCEDURE

single photon emission computed tomography

RADIATION

intensity-modulated radiation therapy

RADIATION

technetium Tc 99m sulfur colloid

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT00743314 - Single-Photon Emission Computed Tomography, Computed Tomography Lymphoscintigraphy, and Intensity-Modulated Radiation Therapy in Treating Patients Who Have Undergone Surgery for Stage I or Stage II Breast Cancer | Biotech Hunter | Biotech Hunter